An open-label, 2-period pharmacokinetic study to evaluate the intra-subject variability in esomeprazole plasma levels in healthy subjects following oral administration of PN 400 [esomeprazole/naproxen] tablets.

Trial Profile

An open-label, 2-period pharmacokinetic study to evaluate the intra-subject variability in esomeprazole plasma levels in healthy subjects following oral administration of PN 400 [esomeprazole/naproxen] tablets.

Completed
Phase of Trial: Phase I

Latest Information Update: 29 Jan 2010

At a glance

  • Drugs Esomeprazole/naproxen (Primary)
  • Indications Arthritis; Musculoskeletal pain; NSAID-induced gastrointestinal damage
  • Focus Pharmacokinetics
  • Sponsors POZEN
  • Most Recent Events

    • 29 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 19 Feb 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top